China Film Co Ltd (600977)
Shanghai Stock Exchange · China · prices in CNY · close of 23 Oct 2026
Key indicators
| Last close | CNY 14.78 |
|---|---|
| 52-week range | 11.76 – 20.76 |
| Return, 1 month / 3 months | +9.5% / +18.5% |
| Return, 1 year / 3 years | +6.0% / +26.5% |
| Trend | Uptrend |
| RSI (14) | 65 |
| Volatility (1 year) | 49.4% |
| Worst drawdown (1 year) | -43.2% |
| Average daily value traded | 446.91M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Film Co Ltd is a Chinese film company based in Beijing. It produces and distributes motion pictures and operates cinemas across the country. The company also handles the import and release of foreign films for the Chinese market and provides film production services and equipment. Its customers include filmmakers, cinema audiences and overseas studios seeking distribution in China. The business spans the making, marketing and screening of films.
On this site China Film Co Ltd appears as a stock on the Shanghai Stock Exchange (China), code 600977, with prices in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Film Co Ltd (600977) trades on the Shanghai Stock Exchange in China. It last closed at CNY 14.78 on 23 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 358 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.0% and over the last three months it rose 18.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 4.7% | ||
| From 52-week high | -28.7% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 18.5% | ||
| 6-month return | 3.4% | ||
| 12-month return, skipping the last month | -3.2% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.2% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 446.91M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +4.5% |
|---|---|
| 1 month | +9.5% |
| 3 months | +18.5% |
| 6 months | +3.4% |
| 1 year | +6.0% |
| 3 years | +26.5% |
| 5 years | +25.3% |
Signals
| 50-day / 200-day average | 13.03 / 14.12 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.48 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Aug 2022 | CNY 0.0400 |
| 12 Aug 2020 | CNY 0.3180 |
| 26 Jul 2019 | CNY 0.2810 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.